Apt Biotech Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
- Paid Up Capital ₹ 6.01 Cr
- Company Age 15 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth 143.35%
- Ebitda 95.94%
- Net Worth 2404.96%
- Total Assets 468751.67%
About Apt Biotech
Apt Biotech Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 April 2009 and has a history of 15 years and ten months. Its registered office is in South West Delhi, Delhi, India.
The Corporate was formerly known as Aquagri Biotech Private Limited. The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 6.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
Abhiram Seth, Rajesh Srivastava, and Sudhakar Tallapragada serve as directors at the Company.
Company Details
- Location
South West Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U73100DL2009PTC189597
- Company No.
189597
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Apr 2009
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Apt Biotech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudhakar Tallapragada  | Director | 17-Jun-2022 | Current |
| Abhiram Seth | Director | 22-Apr-2009 | Current |
| Rajesh Srivastava | Director | 17-Jun-2022 | Current |
Financial Performance of Apt Biotech.
Apt Biotech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 143.35% increase in profit. The company's net worth Soared by an impressive increase of 2404.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apt Biotech?
In 2023, Apt Biotech had a promoter holding of 13.13% and a public holding of 86.87%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ferns Equity Advisors Private LimitedRajesh Srivastava is a mutual person
Prowess Advisors Private LimitedRajesh Srivastava is a mutual person
Lt Foods LimitedAbhiram Seth is a mutual person
Indo-Dutch Chamber Of Business And SciencesRajesh Srivastava is a mutual person
Aquagri Processing Private LimitedAbhiram Seth is a mutual person
Vacmet India LimitedRajesh Srivastava is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Apt Biotech?
Unlock and access historical data on people associated with Apt Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apt Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apt Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
